Hidemi Takahashi
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 19, 2019
Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells.Yuji Tomita, Eri Watanabe, Masumi Shimizu
|May 19, 2019
Suppression of R5-type of HIV-1 in CD4+ NKT cells by Vδ1+ T cells activated by flavonoid glycosides, hesperidin and linarin.Michiyuki Yonekawa, Masumi Shimizu, Atsushi Kaneko
|Jan 17, 2019
Pediatric immunoglobulin A complex secretory component deficiency.Hidehiko Narazaki, Takeshi Yanagihara, Masumi Shimizu
|Jan 01, 2019
Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.Takushi Masu, Masanori Atsukawa, Katsuhisa Nakatsuka
|Oct 17, 2018
Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells.Yohei Otsuka, Eri Watanabe, Eiji Shinya
|Mar 16, 2017
Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of α-galactosylceramide in vivo.Hideki Kogo, Masumi Shimizu, Yasuyuki Negishi
Pageof 1
